Genentech Inc - Company Profile
Powered by 
All the sales intelligence you need on Genentech Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Genentech Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Genentech Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Genentech Inc (Genentech), a subsidiary of Roche Holding AG, is a biotechnology company. It focuses on the discovery, development, manufacture and commercialization of pharmaceuticals for various medical conditions. The company offers its products to specialty distributors, wholesalers, hospital pharmacies and specialist physicians in private practice. Genentech also offers patient support services such as co-pay programs, health insurance, and independent co-pay assistance, among others. The company has more than 40 marketed drugs.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Genentech's R&D arm focuses on applying excellent science to discover and develop potential new medicines with the goal of becoming first-in-class or best-in-class therapeutics. The company's R&D initiatives include sequencing entire human genomes, turning skin cells into heart cells, creating computer chips that mimic brain functions, and applying computation and data science to deliver breakthrough medicines. The company is also involved in AI-driven R&D, speeding clinical trials, and improving manufacturing processes. The R&D unit of Genentech is Genentech Research and Early Development (gRED). This unit is responsible for managing the company's R&D activities, focusing on solving complex health challenges, discovering transformative medicines, and applying advanced computation and data science to drug discovery and development. Genentech Inc has 66 investigational medicines in clinical development, representing one of the largest pipelines in the industry. The company is involved in over 600 active clinical trials worldwide, with approximately 250 active clinical trials in the U.S. The company has over 250 active global partnerships, with around 60% of its R&D pipeline and total Pharma sales involving a partnership. The company has been partnering with companies and research institutes globally for over 20 years to advance health.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer